title: Early detection of premalignant conditions in the colon by fluorescence endoscopy using local sensitization with hexaminolevulinate.
abstract: OBJECTIVE
  We aimed to determine the feasibility of obtaining selective fluorescence of precancerous/cancerous lesions in the colon with a new fluorescence video endoscope system in combination with the selective photosensitizer precursor hexaminolevulinate (HAL), and to carry out a dose-finding study with evaluation of the optimal dose and application time.
  
  
  METHODS
  12 patients with colorectal lesions underwent sensitization with locally applied HAL enemas in two concentrations (0.8 mmol and 1.6 mmol). The examination was conducted either 30 or 60 minutes after rectal administration of the sensitizer, using a special light source capable of delivering either white or blue excitation light. Red fluorescence induced by illumination with blue light was detected via a prototype fluorescence video colonoscope. Biopsies were taken from suspicious areas found with white or blue light. Corresponding endoscopic, fluorescence, and microscopic findings were compared.
  
  
  RESULTS
  Using histological findings as the gold standard, 52/53 of the premalignant/malignant lesions showed red fluorescence under the photodynamic diagnosis (PDD) examination; 38/53 were detected with white-light endoscopy. The PDD mode showed 28 % more polyps than did white-light endoscopic imaging. The greatest fluorescence intensity in precancerous lesions was found with retention for 60 minutes of 500 ml of 1.6 mmol HAL.
  
  
  CONCLUSIONS
  Administration of HAL enema induces selective lesion fluorescence and increases the lesion detection rate in patients with colorectal adenoma and early carcinoma.
authors.affiliation: Department of Medicine II, Hospital Munich-Pasing, Teaching Hospital of University of Munich (LMU), Munich, Germany. brigitte.mayinger@krankenhaus-pasing.de
authors.forename: B
authors.initials: B
authors.lastname: Mayinger
authors.forename: F
authors.initials: F
authors.lastname: Neumann
authors.forename: C
authors.initials: C
authors.lastname: Kastner
authors.forename: K
authors.initials: K
authors.lastname: Degitz
authors.forename: E G
authors.initials: EG
authors.lastname: Hahn
authors.forename: D
authors.initials: D
authors.lastname: Schwab
mesh_terms: D000368:Aged; D000622:Aminolevulinic Acid / Q000031:analogs & derivatives*; D001707:Biopsy, Needle; D003110:Colonic Neoplasms / Q000473:pathology* / Q000517:prevention & control; D003111:Colonic Polyps / Q000175:diagnosis* / Q000473:pathology; D003113:Colonoscopy / Q000379:methods*; D042241:Early Diagnosis; D005240:Feasibility Studies; D005260:Female; D005453:Fluorescence; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D017319:Photosensitizing Agents; D011230:Precancerous Conditions / Q000175:diagnosis* / Q000473:pathology; D012680:Sensitivity and Specificity
chemical_list: D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid; C419924:5-aminolevulinic acid hexyl ester